


Ask a doctor about a prescription for REMINYL 8 PROLONGED-RELEASE HARD CAPSULES
Package Leaflet: Information for the User
galantamine
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Reminyl contains the active substance “galantamine”, an anti-dementia medicine. It is used in adults to treat the symptoms of mild to moderately severe Alzheimer's disease, a type of dementia that affects brain function.
Alzheimer's disease causes increasing memory loss, confusion, and changes in behaviour, making it difficult to carry out daily activities.
It is thought that these effects are caused by a lack of “acetylcholine”, a substance responsible for transmitting messages between brain cells. Reminyl increases the amount of acetylcholine in the brain and in this way treats the signs of the disease.
The capsules are in the form of “prolonged release”. This means that they release the medicine gradually.
Do not take Reminyl
Warnings and precautions
Talk to your doctor or pharmacist before you start taking Reminyl. This medicine should only be used in Alzheimer's disease and is not recommended for other types of memory loss or confusion.
Severe side effects
Reminyl may cause severe skin reactions, heart problems, and seizures. You should be aware of these side effects while taking Reminyl. See section 4 “Be aware of severe side effects”.
Before starting treatment with Reminyl,your doctor should know if you have or have had any of the following conditions:
Your doctor will decide if Reminyl is suitable for you or if the dose needs to be changed.
Tell your doctor if you have recently had an operationon your stomach, intestine, or bladder. Your doctor will decide if Reminyl is suitable for you.
Reminyl may cause weight loss.Your doctor will check your weight regularly while you are taking Reminyl.
Children and adolescents
Reminyl is not recommended for use in children or adolescents.
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Reminyl should not be taken with medicines that work in the same way. These include:
Some medicines may cause side effects more easily in people taking Reminyl. These include:
If you are taking any of these medicines, your doctor may give you a lower dose of Reminyl.
Reminyl may affect some anaesthetics. If you are going to have an operation under general anaesthetic, tell your doctor that you are taking Reminyl well in advance.
Talk to your doctor or pharmacist if you have any questions.
If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Do not breast-feed while you are taking Reminyl.
Reminyl may make you feel dizzy or sleepy, especially during the first few weeks of treatment. If Reminyl affects you, do not drive or use tools or machines.
If your doctor has told you that you have an intolerance to some sugars, talk to them before taking this medicine.
Follow exactly the instructions given to you by your doctor or pharmacist. If you are unsure, ask your doctor or pharmacist again.
If you are taking Reminyl tablets or oral solution and your doctor has told you that they are going to switch you to Reminyl prolonged-release capsules, read carefully the instructions in “Switching from Reminyl tablets or oral solution to Reminyl capsules” in this section.
How much to take
You will start treatment with Reminyl at a low dose. The usual starting dose is 8 mg, taken once a day. Your doctor will gradually increase your dose, every 4 weeks or more, until you reach the dose that is best for you. The maximum dose is 24 mg, taken once a day.
Your doctor will tell you which dose to start with and when to increase it.
If you are unsure what to do or find that the effect of Reminyl is too strong or too weak, talk to your doctor or pharmacist.
Your doctor needs to see you regularly to check that this medicine is working and to talk to you about how you feel.
If you have liver or kidney problems,your doctor may give you a lower dose of Reminyl or may decide that this medicine is not suitable for you.
Switching from Reminyl tablets or oral solution to Reminyl capsules
If you are currently taking Reminyl tablets or oral solution, your doctor may decide to switch you to Reminyl prolonged-release capsules. If this applies to you:
DO NOT take more than one capsule in a day. While you are taking one Reminyl capsule per day, DO NOT take Reminyl tablets or oral solution.
How to take it
Reminyl capsules should be swallowed whole and NOT chewed or crushed. Take your Reminyl dose once a day in the morning, with water or other liquids. Try to take Reminyl with food.
Drink plenty of liquid while you are taking Reminyl to keep yourself hydrated.
If you take more Reminyl than you should
If you have taken too much Reminyl, talk to your doctor or pharmacist immediately or
call the Poison Information Service on 91 562 04 20, stating the name of the medicine and the amount taken. Take the pack with the remaining capsules with you. Signs of an overdose may include:
If you forget to take Reminyl
If you miss a dose, skip that dose and continue with your treatment as usual with your next scheduled dose. DO NOT take a double dose to make up for forgotten doses.
If you miss more than one dose, talk to your doctor.
If you stop taking Reminyl
Talk to your doctor before you stop taking Reminyl. It is important to continue taking this medicine to treat your condition.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Be aware of severe side effects
Stop taking Reminyl and see a doctor or go to the casualty department immediatelyif you notice any of the following side effects:
Skin reactions,including:
These skin reactions are rare in people taking Reminyl (they may affect up to 1 in 1,000 people).
Heart problemsincluding changes in heartbeat (such as slow or extra beats) or palpitations (feeling your heartbeat is fast or irregular). Heart problems can be seen as an abnormal tracing on an “electrocardiogram” (ECG), and may be common in people taking Reminyl (they may affect up to 1 in 10 people).
Seizures. This is uncommon in people taking Reminyl (it may affect up to 1 in 100 people).
You must stop taking Reminyl and seek immediate medical attentionif you notice any of the side effects mentioned.
Other side effects
Very common side effects(may affect more than 1 in 10 people):
Common side effects(may affect up to 1 in 10 people):
Uncommon side effects(may affect up to 1 in 100 people):
Rare side effects(may affect up to 1 in 1,000 people):
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist, even if you think they are not serious. You can also report side effects directly via the Spanish Medicines Surveillance System for Human Use: https://www.notificaram.es/. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the label after EXP. The expiry date is the last day of the month shown.
Do not store above 30°C.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
What Reminyl contains
diethyl phthalate, ethylcellulose, hypromellose, macrogol 400, maize starch, sucrose, gelatin, titanium dioxide (E171), iron oxide black (E172), shellac, and propylene glycol (E1520).
Appearance and packaging
Reminyl 8 mg prolonged-release capsules are white and marked with “G8”. Each pack contains blister packs of 7 or 28 capsules or bottles of 300 capsules.
Not all pack sizes may be marketed.
Marketing authorisation holder and manufacturer
Marketing authorisation holder
Essential Pharma Limited,
Vision Exchange Building,
Triq it-Territorjals, Zone 1,
Central Business District,
Birkirkara, CBD 1070,
Malta
Manufacturer
Janssen-Cilag, SpA
Via C. Janssen
04100 Borgo San Michele
Latina (Italy)
This medicine is authorised in the Member States of the European Union under the following names:
Belgium Reminyl 8 mg hard capsules for prolonged release
Denmark Reminyl 8 mg depotkapsler, hårde
Finland Reminyl 8 mg depotkapseli, kova
Greece Reminyl 8 mg καψ?κια παρατεταμ?νης αποδ?σμευσης, σκληρ?
Ireland Reminyl XL 8 mg prolonged release capsules
Italy Reminyl 8 mg capsule rigide a rilascio prolungato
Luxembourg Reminyl 8 mg gélules dures à libération prolongée
Norway Reminyl 8 mg depotkapsler, hard
Sweden Reminyl 8 mg depotkapslar, hårda
United Kingdom (Northern Ireland) Reminyl XL 8 mg prolonged release capsules
This leaflet was approved in:October 2021.
Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/).
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for REMINYL 8 PROLONGED-RELEASE HARD CAPSULES – subject to medical assessment and local rules.